Skip to main content
Top
Published in: Rheumatology International 4/2013

01-04-2013 | Short Communication

Undifferentiated connective tissue disease in a rheumatology center in Cali, Colombia: clinical features of 94 patients followed for a year

Authors: Luis F. Guerrero, Juan C. Rueda, Raquel Arciniegas, Jorge M. Rueda

Published in: Rheumatology International | Issue 4/2013

Login to get access

Abstract

The aim of the study is to evaluate the clinical and serological features of patients with undifferentiated connective tissue disease (UCTD) of a rheumatology referral center in Cali, Colombia, who were followed for a year. A retrospective analysis of a cohort of patients with an initial diagnosis of UCTD and monitoring for at least 12 months was carried out. A total of 94 patients with UCTD (97.9% women) were evaluated, with an average follow-up of 51 ± 35.7 months. Only 13 patients (13.8%) evolved into a defined connective tissue disease (CTD), of which 8.5% (n:8) developed systemic lupus erythematosus (SLE), 4.2% (n:4) Sjögren syndrome (SS) and 1.1% (n:1) rheumatoid arthritis (RA). A mean period of 35.8 ± 29.2 months between UCTD diagnosis and definite develop of a CTD was found. Arthritis, Raynaud’s phenomenon and photosensitivity were statistically significant (<0.001) for development of CTD. After a mean follow-up of 4.25 years, most of the patients with UCTD showed a favorable evolution. Arthritis, Raynaud’s phenomenon and the presence of photosensitivity were predictors for the development of CTD. It requires a consensus to establish criteria for the classification of UCTD.
Literature
1.
go back to reference Williams HJ, Alarcón GS, Joks R et al (1999) Early undifferentiated tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD. J Rheumatol 26:816–825PubMed Williams HJ, Alarcón GS, Joks R et al (1999) Early undifferentiated tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD. J Rheumatol 26:816–825PubMed
2.
go back to reference Mosca M, Tani C, Bombardieri S (2007) Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology. Best Pract Res Clin Rheumatol 21:1011–1023PubMedCrossRef Mosca M, Tani C, Bombardieri S (2007) Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology. Best Pract Res Clin Rheumatol 21:1011–1023PubMedCrossRef
3.
go back to reference Simmons-O’Brien E, Chen S, Watson R, Antoni C et al (1995) One hundred anti-Ro (SS-A) antibody positive patients: a 10-year follow-up. Medicine (Baltimore) 74:109–130CrossRef Simmons-O’Brien E, Chen S, Watson R, Antoni C et al (1995) One hundred anti-Ro (SS-A) antibody positive patients: a 10-year follow-up. Medicine (Baltimore) 74:109–130CrossRef
4.
go back to reference Bodolay E, Csiki Z, Szekanecz Z et al (2003) Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol 21:313–320PubMed Bodolay E, Csiki Z, Szekanecz Z et al (2003) Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol 21:313–320PubMed
5.
go back to reference Mosca M, Tavoni A, Neri R et al (1998) Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least one year. Lupus 7:95–100PubMedCrossRef Mosca M, Tavoni A, Neri R et al (1998) Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least one year. Lupus 7:95–100PubMedCrossRef
6.
go back to reference Williams HJ, Alarcon GS, Neuner R et al (1998) Early undifferentiated connective tissue disease (CTD). V. An inception cohort 5 years later: disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases. J Rheumatol 25:261–268PubMed Williams HJ, Alarcon GS, Neuner R et al (1998) Early undifferentiated connective tissue disease (CTD). V. An inception cohort 5 years later: disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases. J Rheumatol 25:261–268PubMed
7.
go back to reference Mosca M, Neri R, Bencivelli W et al (2002) Undifferentiated connective tissue disease: analysis of 83 patients with a minimum follow up 5 years. J Rheumatol 29:2345–2349PubMed Mosca M, Neri R, Bencivelli W et al (2002) Undifferentiated connective tissue disease: analysis of 83 patients with a minimum follow up 5 years. J Rheumatol 29:2345–2349PubMed
8.
go back to reference Vaz CC, Couto M, Medeiros D et al (2009) Undifferentiated connective tissue disease: a seven-center cross-sectional study of 184 patients. Clin Rheumatol 28:915–921PubMedCrossRef Vaz CC, Couto M, Medeiros D et al (2009) Undifferentiated connective tissue disease: a seven-center cross-sectional study of 184 patients. Clin Rheumatol 28:915–921PubMedCrossRef
9.
go back to reference Mosca M, Neri R, Bombardieri S (1999) Undifferentiated connective tissue disease: a review of the literature and proposal for preliminary classification criteria. Clin Exp Rheumatol 17:615–620PubMed Mosca M, Neri R, Bombardieri S (1999) Undifferentiated connective tissue disease: a review of the literature and proposal for preliminary classification criteria. Clin Exp Rheumatol 17:615–620PubMed
10.
go back to reference Danieli MG, Fraticelli P, Salvi A et al (1998) Undifferentiated connective tissue diseases: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. Clin Rheumatol 17:195–201PubMedCrossRef Danieli MG, Fraticelli P, Salvi A et al (1998) Undifferentiated connective tissue diseases: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. Clin Rheumatol 17:195–201PubMedCrossRef
11.
go back to reference Danieli MG, Fraticelli P, Franceschini F et al (1999) Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases. Clin Exp Rheumatol 17:585–591PubMed Danieli MG, Fraticelli P, Franceschini F et al (1999) Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases. Clin Exp Rheumatol 17:585–591PubMed
12.
go back to reference Calvo-Alen J, Alarcon GS, Burgard SL et al (1996) Systemic lupus erythematosus: predictors of its occurrence among a cohort of patients with early undifferentiated connective tissue disease: multivariate analyses and identification of risk factors. J Rheumatol 23:469–475PubMed Calvo-Alen J, Alarcon GS, Burgard SL et al (1996) Systemic lupus erythematosus: predictors of its occurrence among a cohort of patients with early undifferentiated connective tissue disease: multivariate analyses and identification of risk factors. J Rheumatol 23:469–475PubMed
13.
go back to reference Vilá LM, Mayor AM, Valentín AH et al (2000) Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus. Lupus 9:110–115PubMedCrossRef Vilá LM, Mayor AM, Valentín AH et al (2000) Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus. Lupus 9:110–115PubMedCrossRef
14.
go back to reference Cavazzana I, Franceschini F, Belfiore N et al (2001) Undifferentiated connective tissue disease with antibodies to Ro/SSa: clinical features and follow-up of 148 patients. Clin Exp Rheumatol 19:403–409PubMed Cavazzana I, Franceschini F, Belfiore N et al (2001) Undifferentiated connective tissue disease with antibodies to Ro/SSa: clinical features and follow-up of 148 patients. Clin Exp Rheumatol 19:403–409PubMed
Metadata
Title
Undifferentiated connective tissue disease in a rheumatology center in Cali, Colombia: clinical features of 94 patients followed for a year
Authors
Luis F. Guerrero
Juan C. Rueda
Raquel Arciniegas
Jorge M. Rueda
Publication date
01-04-2013
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 4/2013
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2234-y

Other articles of this Issue 4/2013

Rheumatology International 4/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.